Silence Therapeutics, Plc. financial statements, including revenue, expenses, profit, and loss

The total revenue of SLNCF for the last quarter is 756.05 k USD, and it's 95.17% lower compared to the previous quarter. The net income of Q2 24 is -19.68 M USD.